Grade 3 Aortic Atheroma on TEE
Grade 3 aortic atheroma on transesophageal echocardiography indicates moderate atherosclerotic disease with plaque thickness of 3 to <4 mm without mobile or ulcerated components, representing an intermediate-risk finding that warrants aggressive medical management and surveillance for embolic complications.
Definition and Classification
Grade 3 atheroma represents moderate atherosclerotic disease in the standardized grading system 1:
- Plaque thickness: ≥3 to <4 mm
- No mobile components
- No ulcerated components
This sits between mild disease (Grade 2: 2 to <3 mm) and severe disease (Grade 4: ≥4 mm), with Grade 5 reserved for any grade with mobile or ulcerated components 1.
Clinical Significance and Risk Stratification
Embolic Risk
Grade 3 atheroma carries significant embolic risk, though less than Grade 4-5 disease. The presence of aortic atheroma is an independent predictor of:
- Ischemic stroke (relative risk 3.8) 2
- Recurrent vascular events (relative risk 3.5) 2
- Cardiovascular death 2
These risks persist independent of carotid stenosis, atrial fibrillation, or peripheral artery disease 2.
Long-term Mortality
Any grade of aortic atheroma significantly increases long-term all-cause mortality in cardiac surgical patients, and this relationship is independent of conventional risk factors and postoperative stroke 3. This underscores that Grade 3 disease is not benign.
Natural History
The disease demonstrates morphologic stability in approximately 66% of patients over one year, but individual lesion morphology is dynamic 4:
- Progression occurs in 23-29% of cases
- Regression occurs in 9-10% of cases
- Mobile components can develop even from lower-grade disease
Management Approach
Medical Therapy (Essential)
Aggressive atherosclerosis risk factor modification is mandatory 2:
- Statin therapy: Target LDL-C <1.4 mmol/L (55 mg/dL) 1
- Antiplatelet therapy: Single antiplatelet therapy is reasonable; data on anticoagulation are mixed with theoretical concerns about plaque hemorrhage causing atheroembolic syndrome 2
- Blood pressure control: Hypertension is present in 80% of cases 1
- Lifestyle modifications: Smoking cessation, diet, exercise
Surveillance Strategy
Follow-up imaging is warranted given the dynamic nature of atheroma:
- Consider repeat TEE or alternative imaging (CT angiography) at 6-12 months to assess for progression, particularly development of mobile components
- More frequent imaging if symptoms develop or if progression to Grade 4-5 is suspected
Surgical Considerations
If cardiac surgery is planned, Grade 3 atheroma requires:
- Intraoperative epiaortic ultrasound to guide surgical technique 2
- Modification of cannulation/cross-clamping sites to avoid manipulation of diseased segments
- Consider off-pump techniques if feasible to reduce embolic risk 2
Key Clinical Pitfalls
- Do not dismiss Grade 3 as "mild": It carries significant embolic and mortality risk
- Mobile components change everything: If any mobility or ulceration is present, this becomes Grade 5 (complex plaque) with substantially higher risk
- Systemic disease marker: Grade 3 atheroma correlates strongly with coronary artery disease (sensitivity 75.9%, specificity 67.7%) 5, warranting evaluation for CAD
- Stroke pattern: Patients with aortic atheroma frequently present with small cortical infarcts rather than large territorial strokes, distinguishing them from typical cardioembolic or large artery atherosclerosis patterns 6
Context-Specific Considerations
In trauma settings: The grading system differs—Grade 3 blunt aortic injury may warrant repair 7, but this is unrelated to atherosclerotic grading.
In stroke workup: Grade 3 atheroma may explain cryptogenic strokes and should prompt consideration of atheroma as the embolic source rather than pursuing extensive cardiac workup 2.